(Q47981586)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9624390%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

title

Proliferating cell nuclear antigen in laryngeal cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9624390%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

0 references

T Krecicki

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9624390%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

M Jeleń

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9624390%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

publication date

1 March 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9624390%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

number of pages

4

1 reference

Journal of Laryngology and Otology

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9624390%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

112

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9624390%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9624390%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

310-313

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9624390%20AND%20SRC:MED&resulttype=core&format=json

Immunoreactivity of proliferating cell nuclear antigen in salivary gland tumours: an assessment of growth potential

12 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0022215100158451

7 January 2021

The assessment of proliferating cell nuclear antigen (PCNA) immunostaining in primary gastrointestinal lymphomas and its relationship to histological grade, S+G2+M phase fraction (flow cytometric analysis) and prognosis

1 reference

https://api.crossref.org/works/10.1017%2FS0022215100158451

7 January 2021

EGFR and PCNA expression in oral squamous cell carcinomas--a valuable tool in estimating the patient's prognosis

1 reference

https://api.crossref.org/works/10.1017%2FS0022215100158451

7 January 2021

Sequential increases in proliferating cell nuclear antigen expression in head and neck tumorigenesis: a potential biomarker

1 reference

https://api.crossref.org/works/10.1017%2FS0022215100158451

7 January 2021

Has the cellular proliferation marker Ki67 any clinical relevance in squamous cell carcinoma of the head and neck?

1 reference

https://api.crossref.org/works/10.1017%2FS0022215100158451

7 January 2021

Argyrophilic nucleolar organizer region counts and proliferating cell nuclear antigen scores are two reliable indicators of survival in pharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1017%2FS0022215100158451

7 January 2021

Nuclear DNA content, proliferating-cell nuclear antigen (PCNA) and p53 immunostaining in predicting progression of laryngeal cancer in situ lesions

1 reference

https://api.crossref.org/works/10.1017%2FS0022215100158451

7 January 2021

Proliferating cell nuclear antigen counts as markers of cell proliferation in head and neck cancer

1 reference

https://api.crossref.org/works/10.1017%2FS0022215100158451

7 January 2021

Prognostic value of proliferating cell nuclear antigen in gastric carcinoma

1 reference

https://api.crossref.org/works/10.1017%2FS0022215100158451

7 January 2021

The expression of proliferating cell nuclear antigen in paraffin sections of peripheral, node-negative non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1017%2FS0022215100158451

7 January 2021

Cell proliferation of transitional cell bladder tumours determined by PCNA/cyclin immunostaining and its prognostic value

1 reference

https://api.crossref.org/works/10.1017%2FS0022215100158451

7 January 2021

Relationship of proliferating cell nuclear antigen (PCNA) in prostatic carcinomas to various clinical parameters

1 reference

https://api.crossref.org/works/10.1017%2FS0022215100158451

7 January 2021

Proliferating cell nuclear antigen (PCNA) in medullary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1017%2FS0022215100158451

7 January 2021

Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms.

1 reference

https://api.crossref.org/works/10.1017%2FS0022215100158451

7 January 2021

Predicting recurrence and survival in patients with laryngeal cancer by means of DNA cytometry, tumor front grading, and proliferation markers

1 reference

https://api.crossref.org/works/10.1017%2FS0022215100158451

7 January 2021

Expression of EGF, EGFR and PCNA in laryngeal lesions.

1 reference

https://api.crossref.org/works/10.1017%2FS0022215100158451

7 January 2021

Proliferating cell nuclear antigen in malignant and pre-malignant lesions of epithelial origin in the oral cavity and the skin: an immunohistochemical study

1 reference

https://api.crossref.org/works/10.1017%2FS0022215100158451

7 January 2021

High correlation with survival of proliferating cell nuclear antigen expression in mucoepidermoid carcinoma of the parotid gland

1 reference

https://api.crossref.org/works/10.1017%2FS0022215100158451

7 January 2021

10.1017/S0022215100158451

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9624390%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference